Merck to Buy Terns in $6.7 Billion DealMar 25, 2026Merck & Co. agreed to acquire Terns Pharmaceuticals for $6.7 billion at $53 per share, representing a 31% premium, with the transaction expected to close within three months.Merck to Buy Terns in $6.7 Billion DealcenTopic tracking2026-03-25Merck to Buy Terns in $6.7 Billion Deal2026-06-29Merck Agrees to Acquire Bio-Techne for $11.3 Billion
ChemBrief